RxDoctor Payments Data

James Chmiel

Pediatric Pulmonology · Indianapolis, INNPI 1932126968

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $187 of the $302 with a category attached, or 61.8%. 6 manufacturers reported payments, led by Acclarent, Inc at 36.5% of the total. Reporting peaked in 2020 at $110 and has fallen 59.9% since, to $44 in 2025. That places this record below the midpoint for pediatric pulmonology clinicians in IN, where the typical reported total is $302.

$302in general payments, 2019–2025

Across 6 payments — averaging $50.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$110
  • Chiesi USA, Inc.$71
  • Viatris Specialty LLC$44
  • AstraZeneca$34
  • Vertex$30
  • Gilead$13
$1,191,226in research payments, 2019–2025

Across 37 payments — averaging $32,195 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$1.2M
  • Novartis$600

What the payments were for

  • Food & beverage$18762%
  • Education$4415%
  • Gifts$7124%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$302 in reported general payments places this provider in the 50th percentile of 32 pediatric pulmonology providers in Indiana.

See all pediatric pulmonology providers in Indiana

Other pediatric pulmonology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →